A Complete Nonclinical GLP Tox Study Package for a Successful IND Submission in Six Months

Author

Latest Blogs

Why CDMO Outsourcing is Moving Earlier in Biologics Development

More
Infographic showing the shift from traditional pharma outsourcing based on cost and capacity to a new-age CRDMO model focused on scientific depth, speed, supply-chain resilience, integration, and development flexibility.

The New-Age CRDMO: Rethinking Drug Development Partnerships

More

Flow Chemistry Approaches for Poorly Soluble Pharmaceutical Intermediates

More

Advanced Strategies for Handling Unstable Intermediates with Flow Chemistry

More

Electrochemical cell design: Turning electron transfer into a practical synthetic tool

More
Semi-targeted integration in cell line development supports stable clone selection and more predictable biologics development.

From Faster CLD to Smarter CMC Decisions: How Semi-Targeted Integration Changes the Biologics Game

More